Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




CT Imaging Alone Found Noninferior to CT/MR Combo for Acute Ischemic Stroke Patients

By HospiMedica International staff writers
Posted on 25 Jul 2022

More than 90% of patients with acute ischemic stroke (AIS) receive magnetic resonance imaging (MRI) in addition to computed tomography (CT) with few data to determine whether there is an associated benefit with patient outcomes. More...

Now, a new study of patients hospitalized with AIS has found that a diagnostic imaging strategy of initial CT alone was noninferior to initial CT with additional MRI with regard to the clinical outcomes of death or dependence at hospital discharge or prevention of stroke or death at one year after discharge.

The study by researchers at the Duke University Medical Center (Durham, NC, USA) involved 246 participants with a median age of 68 years and 131 being men (53%). The researchers found that death or dependence at discharge occurred more often in patients with additional MRI (59 of 123 [48%]) than in those with CT alone (52 of 123 [42.3%]); meeting the −7.50% criterion for noninferiority. Stroke or death within one year after discharge determined for 225 of 235 (96%) survivors occurred more often in patients with additional MRI (22 of 113 [19.5%]) than in those with CT alone (14 of 112 [12.5%]), meeting the 0.725 relative risk criterion for noninferiority.

Based on the findings of the propensity score-matched cohort study of patients hospitalized with AIS, the researchers concluded that a diagnostic imaging strategy of initial CT alone was noninferior to initial CT plus additional MRI with regard to clinical outcomes at discharge and at one year. Further research is needed to determine which patients hospitalized with acute ischemic stroke benefit from MRI, according to the researchers.

Related Links:
Duke University Medical Center 


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.